Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 151 - 165 of 531 items.
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12
Shelf Life Extension for the SPIKEVAX (elasomeran) COVID-19 Vaccine with Printed Expiry Dates on Vial and Carton Labels
AlertHealth professional risk communication | 2022-01-11
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
AlertHealth professional risk communication | 2022-01-07
Herberex may pose serious health risks; Health Canada suspends product licence
AlertPublic advisory | 2021-12-31
Potential contamination of health products manufactured by Eco-Med Pharmaceuticals Inc. may pose health risks to Canadians
AlertPublic advisory | 2021-12-20
Multiple cold and flu powdered medications, for adults and children 12 years of age and older, recalled due to potential health risks
AlertPublic advisory | 2021-12-20
Dr. pen microneedling devices are not authorized for sale and may pose health risks
AlertPublic advisory | 2021-12-16
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation for Use in Children Aged 5 Years to Less Than 12 Years
AlertHealth professional risk communication | 2021-11-19
Recall: Three lots of Odor-Eaters Spray Powder for athlete’s foot
AlertPublic advisory | 2021-11-19
Button batteries pose life-threatening dangers to young children
AlertPublic advisory | 2021-11-15
One lot of Verkazia (cyclosporine) eye drops recalled due to potential presence of particulate matter
AlertPublic advisory | 2021-11-12
Distribution of SPIKEVAX (elasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-11-10
Health Canada is updating the labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines
AlertPublic advisory | 2021-11-09